Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer

ConclusionsWe found that high DCBLD2 expression correlated with a poor clinical outcome, as well as tumorigenesis, invasion and metastasis of CRC cells. DCBLD2 may serve as a prognostic biomarker and a novel therapeutic target for CRC.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research